Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
Key Details
- 1scSurvival is a machine learning model designed for single-cell resolution analysis in cancer assessment.
- 2Developed with NIH funding by Oregon Health & Science University researchers.
- 3Tested on data from over 150 cancer patients, the tool linked specific tumor and immune cell populations to varying risk and survival outcomes.
- 4The model outperformed traditional methods in predicting outcomes in melanoma and liver cancer.
- 5Research appeared in the journal Cancer Discovery on April 21, 2026.
Why It Matters
Single-cell analytics and AI are at the cutting edge of precision oncology, offering deeper insight into tumor heterogeneity and treatment response. These advances may significantly enhance radiology's role in prognostication and personalized care, especially as multi-modal data integration becomes more common.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.